Summary
- Current Price
- As of today, RDY price is $12.11, down -2.50% on
- Current Price All-Time High
- RDY price is currently -28.31% below its historical high of $16.89 set on
- Market Cap
- RDY current market cap is $10B, down -14.34% year-over-year
- PE Ratio
- RDY current PE ratio is 27.21
- Revenue
- RDY current annual revenue is $3.80B, down -1.26% year-over-year
- Next Earnings
- The next earnings release for RDY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Dr. Reddy's Laboratories Limited |
| Ticker | NYSE: RDY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | India |
| IPO | |
| Indexes | Not included |
| Website | drreddys.com |
| Employees | 27,811 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $12.11 | |
| Price, 1D Change | -2.50% | |
| Market Cap | $10B | |
| TTM Dividend Yield | 0.69% | |
| PE Ratio | 27.21 | |
| Beta | 0.21 | |
| Revenue | $3.80B | |
| Revenue, 1Y Change | -1.26% | |
| EPS | $0.58 | |
| EPS, 1Y Change | -27.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.08 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $0.58 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $3.80B | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $12.11 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.81 | - | |
| - | $0.80 | - | |
| - | $0.58 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $3.37B | - | |
| - | $3.85B | - | |
| - | $3.80B | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -14.17% | |
| Price, 3Y | -14.53% | |
| Market Cap, 1Y | -14.34% | |
| Market Cap, 3Y | -14.33% | |
| Revenue, 1Y | -1.26% | |
| Revenue, 3Y | +24.27% | |
| EPS, 1Y | -27.40% | |
| EPS, 3Y | -13.66% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $12.11 | |
| SMA 200 | $13.56 | |
| SMA 50 | $13.03 | |
| EMA 200 | $13.48 | |
| EMA 50 | $12.76 | |
| MACD | -$0.19 | |
| Beta | 0.21 | |
| ATR | $0.29 | |
| 14-Day RSI | 41.77 | |
| 10-Day Volatility | 17.48% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.08 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.77% | |
| Total Dividend | $0.09 | |
| $75.36M | ||
| 15.68% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $3.80B | |
| EPS | $0.58 | |
| Gross Profit | $0.00 | |
| Gross Margin | 52.77% | |
| Operating Income | $525.62M | |
| Operating Margin | 13.83% | |
| Net Income | $480.61M | |
| Net Margin | 12.64% | |
| EBITDA | $758.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.21 | |
| 1.80 | ||
| 1.35 | ||
| - | ||
| 6 | ||
| 4.92 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 27.21 | |
| 2.76 | ||
| 2.49 | ||
| 16.54 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $4.01B | |
| $925.83M | ||
| $6.11B | ||
| $3.18B | ||
| $2.10B | ||
| $1.77B | ||
| Total Debt | $815.41M | |
| $686.76M | ||
| $352.26M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $3.32B | ||
| $1.48B | ||
| $1.80B | ||
| $0.00 | ||
| $233.20M | ||
| $0.00 | ||
| $139.78M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $609.28M | ||
| -$758.66M | ||
| $144.08M | ||
| Capex | $434.88M | |
| $174.40M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HSBC | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | ||
| Barclays | ||
| Barclays | ||
| Barclays |
Analyst sentiment
Institutional ownership
Screeners with RDY
FAQ
- What is the ticker symbol for Dr. Reddy's Laboratories Limited?
- The ticker symbol for Dr. Reddy's Laboratories Limited is NYSE:RDY
- Does Dr. Reddy's Laboratories Limited pay dividends?
- Yes, Dr. Reddy's Laboratories Limited pays dividends. The last payment was $0.08, with an ex-dividend date on July 24, 2026
- What sector is Dr. Reddy's Laboratories Limited in?
- Dr. Reddy's Laboratories Limited is in the Healthcare sector
- What industry is Dr. Reddy's Laboratories Limited in?
- Dr. Reddy's Laboratories Limited is in the Specialty & Generic Drug Manufacturers industry
- What country is Dr. Reddy's Laboratories Limited based in?
- Dr. Reddy's Laboratories Limited is headquartered in India
- When did Dr. Reddy's Laboratories Limited go public?
- Dr. Reddy's Laboratories Limited initial public offering (IPO) was on April 11, 2001
- Is Dr. Reddy's Laboratories Limited in the S&P 500?
- No, Dr. Reddy's Laboratories Limited is not included in the S&P 500 index
- Is Dr. Reddy's Laboratories Limited in the NASDAQ 100?
- No, Dr. Reddy's Laboratories Limited is not included in the NASDAQ 100 index
- Is Dr. Reddy's Laboratories Limited in the Dow Jones?
- No, Dr. Reddy's Laboratories Limited is not included in the Dow Jones index
- When was Dr. Reddy's Laboratories Limited last earnings report?
- Dr. Reddy's Laboratories Limited's most recent earnings report was on July 22, 2026
- When does Dr. Reddy's Laboratories Limited report earnings?
- The next expected earnings date for Dr. Reddy's Laboratories Limited is October 22, 2026
Data Sources & References
- RDY Official Website www.drreddys.com
- RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
- RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy